コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 al analog pain scale of the Multidimensional Health Assessment Questionnaire.
2 nd on functional outcome, as assessed by the Health Assessment Questionnaire.
3 were collected by using a modified Stanford Health Assessment Questionnaire.
4 sight on QoL questionnaire and the Childhood Health Assessment Questionnaire.
5 come data collected included the Scleroderma Health Assessment Questionnaire.
6 ation of hand function using the Scleroderma Health Assessment Questionnaire.
7 tion rate 33 mm/hour versus 20, and modified Health Assessment Questionnaire 1.0 versus 0.4 (P < 0.01
8 daily living (ADL) question of the Modified Health Assessment Questionnaire; a question about the du
9 udinal outcome study by mailed comprehensive Health Assessment Questionnaire administered every 6 mon
10 Rodnan skin thickness score and the modified Health Assessment Questionnaire after 12 months of oral
11 , the cross-cultural adaptation of the Child Health Assessment Questionnaire and the Child Health Que
12 omic issues and functional status (using the Health Assessment Questionnaire and the Health Status Qu
13 tive patients were followed up with biannual Health Assessment Questionnaires and medical record audi
14 Cumulative disability was determined with a health-assessment questionnaire and scored on a scale of
15 es, QOL as measured by the Short Form 36 and Health Assessment Questionnaire, and diagnosis reassessm
16 ional disability as measured by the modified Health Assessment Questionnaire, and erythrocyte sedimen
17 alog scales for pain and general health, the Health Assessment Questionnaire, and erythrocyte sedimen
18 ry measurements were pulmonary function, the Health Assessment Questionnaire, and other measures of s
19 patient's global assessments, ESR, modified Health Assessment Questionnaire, and patient's pain asse
20 nd stiffness of the target joint, a modified Health Assessment Questionnaire, and the EuroQol 5-domai
21 aversion-Openness Personality Inventory, the Health Assessment Questionnaire, and the Psychosocial Ad
22 skin thickness score (MRSS), the Scleroderma Health Assessment Questionnaire, assessment of organ-bas
24 28-joint Disease Activity Score (P = 0.023), health assessment questionnaire disability (P = 0.05), t
25 modified Rodnan skin thickness score (MRSS), Health Assessment Questionnaire disability index (HAQ DI
26 6; DAS28-4(ESR)-defined remission, change in Health Assessment Questionnaire Disability Index (HAQ-DI
27 s (P = 0.0119), handspread (P = 0.0242), and Health Assessment Questionnaire disability index (HAQ-DI
29 by modified Rodnan skin scores and modified health assessment questionnaire disability index (mHAQ-D
30 physical function according to scores on the Health Assessment Questionnaire Disability Index (odds r
31 had at least 0.5 units of improvement in the Health Assessment Questionnaire disability index (P < 0.
32 yment status, and functional disability (the Health Assessment Questionnaire disability index [HAQ DI
33 f-reported physical function status with the Health Assessment Questionnaire Disability Index and ass
34 actor of 3 with each 1-point increase in the Health Assessment Questionnaire disability index modifie
36 08; P < .001) and overall function (modified Health Assessment Questionnaire Disability Index, -1.03;
37 nal Health Assessment Questionnaire (MDHAQ), Health Assessment Questionnaire Disability index, and He
38 , ACR50, and ACR70 responses, scores for the Health Assessment Questionnaire disability index, the 3-
39 lling, and joint effusion) measured with the Health Assessment Questionnaire Disability Index, the Di
40 ypes, baseline log C-reactive protein level, Health Assessment Questionnaire Disability Index, total
42 Patients with highly abnormal values on the Health Assessment Questionnaire Disability Scale, global
44 month 3 and the change from baseline in the Health Assessment Questionnaire-Disability Index (HAQ-DI
45 e) and the change from baseline score on the Health Assessment Questionnaire-Disability Index (HAQ-DI
46 scale (ACR 20), the change from baseline in Health Assessment Questionnaire-Disability Index (HAQ-DI
47 (ACR20) (ie, RR, 0.94 to 1.06), and for the Health Assessment Questionnaire-Disability Index (HAQ-DI
48 from baseline to month 3 in the score on the Health Assessment Questionnaire-Disability Index (HAQ-DI
49 0% (ACR20) response (primary end point), the Health Assessment Questionnaire-Disability Index (HAQ-DI
50 including function measured by the modified Health Assessment Questionnaire, disease activity measur
51 ile of functional status, as measured by the Health Assessment Questionnaire, experienced direct medi
52 er scores indicate more limitations) and the Health Assessment Questionnaire for the Spondylarthropat
54 , scored in a manner similar to that for the Health Assessment Questionnaire (HAQ) (range 0-3), were
55 Physical functioning was assessed using the Health Assessment Questionnaire (HAQ) and clinical respo
56 and musculoskeletal stiffness with modified Health Assessment Questionnaire (HAQ) and quality of lif
57 sion, osteitis, and synovitis, scores on the Health Assessment Questionnaire (HAQ) and the Short Form
58 neric health status/QOL were assessed by the Health Assessment Questionnaire (HAQ) and the Short Form
59 is (RA) by using the disability index of the Health Assessment Questionnaire (HAQ) as the measure of
61 imal improvements evident at 6 months in the Health Assessment Questionnaire (HAQ) disability index (
63 The course of changes in lung function, the Health Assessment Questionnaire (HAQ) disability index (
64 epression Scale (CES-D; range 0-60), and the Health Assessment Questionnaire (HAQ) disability index (
65 Physical function was assessed using the Health Assessment Questionnaire (HAQ) disability index (
66 ealth status: the Short Form 36 (SF-36), the Health Assessment Questionnaire (HAQ) disability index (
67 f Chronic Illness Therapy-Fatigue (FACIT-F), Health Assessment Questionnaire (HAQ) Disability Index (
69 Study Short Form 36 (SF-36) and the Stanford Health Assessment Questionnaire (HAQ) Disability Index (
70 rm 36 (SF-36) modified health survey and the Health Assessment Questionnaire (HAQ) disability index a
71 tudy Short Form 36 (MOS SF-36), and Stanford Health Assessment Questionnaire (HAQ) Disability Index a
73 l disability, as reflected by scores for the Health Assessment Questionnaire (HAQ) disability index,
74 of skin disease (r = 0.69, P < 0.0001), and Health Assessment Questionnaire (HAQ) disability scores
77 tology classification criteria for RA, had a Health Assessment Questionnaire (HAQ) score collected, a
80 ine and the swollen and tender joint counts, Health Assessment Questionnaire (HAQ) scores, C-reactive
81 oms, examination of inflamed joints, and the Health Assessment Questionnaire (HAQ) were the main meas
83 nalog scale), physical function score on the Health Assessment Questionnaire (HAQ), and levels of an
84 radiographs, functional evaluation using the Health Assessment Questionnaire (HAQ), and quality of li
85 assessed using the following tools: QWB-SA, Health Assessment Questionnaire (HAQ), Arthritis Impact
86 st, Fibromyalgia Impact Questionnaire (FIQ), Health Assessment Questionnaire (HAQ), Short Form Health
87 ulcers and infarcts; patients completed the Health Assessment Questionnaire (HAQ), the Arthritis Imp
88 Survey (SF-36), the disability index of the Health Assessment Questionnaire (HAQ), the Nail Psoriasi
89 d physical performance, as measured with the Health Assessment Questionnaire (HAQ), the Valued Life A
90 lean mass with disability, measured with the Health Assessment Questionnaire (HAQ), were explored for
91 Functional ability was assessed using the Health Assessment Questionnaire (HAQ), with adjustment f
96 es included the disability index (DI) of the Health Assessment Questionnaire (HAQ); Disease Activity
98 as their physical function (according to the Health Assessment Questionnaire [HAQ] disability index [
100 utcomes included disease activity, function (Health Assessment Questionnaire [HAQ] score), and RA qua
101 ing QOL (Short Form 36 [SF-36]), disability (Health Assessment Questionnaire [HAQ]), and mood (Hospit
102 Disability was assessed by the Childhood Health Assessment Questionnaire, health-related quality
103 Larsen method), functional assessment by the Health Assessment Questionnaire, history of joint surger
105 d assessments of daily functioning (Stanford Health Assessment Questionnaire, Lawton Instrumental Act
106 Disability was measured with the modified Health Assessment Questionnaire (M-HAQ) and the physical
107 tive patients with RA completed the modified Health Assessment Questionnaire (M-HAQ) and the Short Fo
109 ologic Studies Depression Scale and Modified Health Assessment Questionnaire (M-HAQ) scores, demograp
111 ct Questionnaire (FIQ), the Multidimensional Health Assessment Questionnaire (MDHAQ), the pain improv
112 ng self-report questionnaires: HAP, Modified Health Assessment Questionnaire, Medical Outcomes Study
113 self-report joint counts, function (modified Health Assessment Questionnaire [mHAQ]), self efficacy,
114 mes included CR at weeks 4 and 12, function (Health Assessment Questionnaire), pain (0-100-mm visual
116 llowup evaluations with use of the Childhood Health Assessment Questionnaire, physician global assess
117 = -0.57 for Sharp's score), and the Modified Health Assessment Questionnaire (r = 0.38 for NDJ, and r
119 of 152), and functional disability by Child Health Assessment Questionnaire score >0 (53 [68%] of 11
120 sus 5.1), and had greater disability (median Health Assessment Questionnaire score 2.1 versus 1.6).
123 dels, age at onset, male sex, RF positivity, Health Assessment Questionnaire score>or=1.5, and nodule
124 rction, low-dose aspirin, comorbidity score, Health Assessment Questionnaire score, and presence of t
125 did not predict SRC included age, sex, race, Health Assessment Questionnaire score, fist closure, han
126 int disease activity score (DAS28), baseline health assessment questionnaire score, gender and concur
127 rivation Index were also predictive, but the Health Assessment Questionnaire score, rheumatoid factor
128 rheumatoid factor, nodular disease, modified Health Assessment Questionnaire score, taking CVD drugs,
129 linically important improvements in modified Health Assessment Questionnaire scores compared with pat
130 fter 2 years, significant differences in the Health Assessment Questionnaire scores remained, but the
131 ssment of disease activity, and the modified Health Assessment Questionnaire scores were collected.
133 from baseline in the disability index of the Health Assessment Questionnaire showed greater decreases
134 ical component sections of the Short-Form 36 Health Assessment Questionnaire than did antibiotic-trea
135 mal clinically important difference of Child Health Assessment Questionnaire, the cross-cultural adap
137 ty in the DAS and other RA scales (e.g., the Health Assessment Questionnaire) to recommend them as so
138 amble technique [SG]), disability (Childhood Health Assessment Questionnaire), VAS of pain, and VAS o
139 , physician global disease rating, Childhood Health Assessment Questionnaire); visits (PV = 941) with
142 owing infliximab therapy, measured using the Health Assessment Questionnaire, was significantly assoc
143 e, and functional ability as measured by the Health Assessment Questionnaire were determined before a
145 y, the swollen joint count, and function (by Health Assessment Questionnaire) were all significantly